Drug Residues Relative to Food Safety in Avian and Small Ruminants
A special issue of Animals (ISSN 2076-2615). This special issue belongs to the section "Veterinary Clinical Studies".
Deadline for manuscript submissions: closed (20 March 2022) | Viewed by 4844
Special Issue Editor
Special Issue Information
Dear Colleagues,
Drug residue avoidance in animal products consumed by humans is a food safety focus worldwide. Continued access to antibiotics is critical to veterinary medicine. However, administration of these drugs to animals must be judicious in order to protect public health, with assurance that drug residues do not enter the human food chain.
For cattle, chickens, and swine there are numerous agency approved medications and mandated withdrawal times. In contrast, approved drugs for minor species, such as game birds and small ruminants, are limited. Therefore, drug administration to these minor species is often based on extrapolation from a related species or animal class.
The aim of this Special Issue is to publish original research papers or reviews concerning the use of antibiotics in birds and small ruminants to highlight the importance of pharmacokinetic and residue depletion studies. While live animal pharmacokinetic studies provide some insights into residue avoidance, tissue residue studies are the gold standard for accurately estimating withdrawal intervals. Other methods for estimating withdrawal interval recommendations, such as physiologically-based pharmacokinetic and non-linear mixed effect models, also play important roles in estimating withdrawal intervals.
I look forward to you sharing your recent findings through this Special Issue.
Prof. Dr. Lisa Tell
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Animals is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medications
- drug residues
- tissues
- pharmacokinetics
- extra-label drug use
- withdrawal intervals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.